Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...
The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...
Zymo Research partners with biomodal to offer advanced multiomic sequencing, enabling 5mC, 5hmC and genetic analysis from a ...
In this edition of the biotech bi-weekly, we highlight the latest exciting product launches, partnerships and company events.
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si, a Connecticut-based start-up, today introduced the world’s first next-generation protein sequencing platform at Cowen Healthcare 2020. The Quantum-Si ...
Illumina and next-gen sequencing (NGS) are synonymous. But to anyone paying attention, the company’s recent emphasis on multiomics has been hard to miss. Indeed, the company has launched both ...
Miami University’s Center for Bioinformatics and Functional Genomics (CBFG) has become one of the first institutions in the region to acquire the PacBio VEGA Benchtop System — a cutting-edge DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results